Woodline Partners LP Akebia Therapeutics, Inc. Transaction History
Woodline Partners LP
- $17.6 Billion
- Q2 2025
A detailed history of Woodline Partners LP transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 1,001,360 shares of AKBA stock, worth $3.06 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,001,360
Previous 2,485,578
59.71%
Holding current value
$3.06 Million
Previous $4.77 Million
23.64%
% of portfolio
0.02%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding AKBA
# of Institutions
169Shares Held
105MCall Options Held
134KPut Options Held
262K-
Vanguard Group Inc Valley Forge, PA14.6MShares$44.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$35.6 Million0.0% of portfolio
-
State Street Corp Boston, MA8MShares$24.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.07MShares$18.6 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$17.6 Million20.26% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $563M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...